374 related articles for article (PubMed ID: 19168402)
21. Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry.
Le Saux T; Chhun S; Rey E; Launay O; Weiss L; Viard JP; Pons G; Jullien V
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 865(1-2):81-90. PubMed ID: 18325857
[TBL] [Abstract][Full Text] [Related]
22. Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression.
Ford J; Cornforth D; Hoggard PG; Cuthbertson Z; Meaden ER; Williams I; Johnson M; Daniels E; Hsyu P; Back DJ; Khoo SH
Antivir Ther; 2004 Feb; 9(1):77-84. PubMed ID: 15040539
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of lopinavir and ritonavir in peripheral blood mononuclear cells, plasma, and ultrafiltrate using a selective and highly sensitive LC/MS/MS assay.
Ehrhardt M; Möck M; Haefeli WE; Mikus G; Burhenne J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):249-58. PubMed ID: 17161668
[TBL] [Abstract][Full Text] [Related]
24. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
Poirier JM; Robidou P; Jaillon P
Ther Drug Monit; 2005 Apr; 27(2):186-92. PubMed ID: 15795650
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
[TBL] [Abstract][Full Text] [Related]
26. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography.
Hirabayashi Y; Tsuchiya K; Kimura S; Oka S
Biomed Chromatogr; 2006 Jan; 20(1):28-36. PubMed ID: 15971289
[TBL] [Abstract][Full Text] [Related]
28. Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma.
Gehrig AK; Mikus G; Haefeli WE; Burhenne J
Rapid Commun Mass Spectrom; 2007; 21(16):2704-16. PubMed ID: 17639576
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
Poirier JM; Robidou P; Jaillon P
Ther Drug Monit; 2002 Apr; 24(2):302-9. PubMed ID: 11897976
[TBL] [Abstract][Full Text] [Related]
30. Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells.
Elens L; Veriter S; Yombi JC; Di Fazio V; Vanbinst R; Lison D; Wallemacq P; Vandercam B; Haufroid V
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1805-14. PubMed ID: 19487167
[TBL] [Abstract][Full Text] [Related]
31. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
Weller DR; Brundage RC; Balfour HH; Vezina HE
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
[TBL] [Abstract][Full Text] [Related]
32. Direct and fast determination of antiretroviral drugs by automated online solid-phase extraction-liquid chromatography-tandem mass spectrometry in human plasma.
Koal T; Sibum M; Koster E; Resch K; Kaever V
Clin Chem Lab Med; 2006; 44(3):299-305. PubMed ID: 16519602
[TBL] [Abstract][Full Text] [Related]
33. Liquid chromatography-tandem mass spectrometric assay for the nucleoside reverse transcriptase inhibitor emtricitabine in human plasma.
Sparidans RW; Prins JM; Schellens JH; Beijnen JH
Biomed Chromatogr; 2007 Jun; 21(6):621-7. PubMed ID: 17340566
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Crommentuyn KM; Rosing H; Hillebrand MJ; Huitema AD; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):359-67. PubMed ID: 15081931
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a liquid chromatographic/tandem mass spectrometric assay for the quantitation of nucleoside HIV reverse transcriptase inhibitors in biological matrices.
Compain S; Schlemmer D; Levi M; Pruvost A; Goujard C; Grassi J; Benech H
J Mass Spectrom; 2005 Jan; 40(1):9-18. PubMed ID: 15643642
[TBL] [Abstract][Full Text] [Related]
36. HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.
D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Bonora S; Di Perri G
J Pharm Biomed Anal; 2010 Sep; 52(5):774-80. PubMed ID: 20236784
[TBL] [Abstract][Full Text] [Related]
37. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells.
Capron A; Musuamba F; Latinne D; Mourad M; Lerut J; Haufroid V; Wallemacq PE
Ther Drug Monit; 2009 Apr; 31(2):178-86. PubMed ID: 19057467
[TBL] [Abstract][Full Text] [Related]
38. Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
Villani P; Feroggio M; Gianelli L; Bartoli A; Montagna M; Maserati R; Regazzi MB
Ther Drug Monit; 2001 Aug; 23(4):380-8. PubMed ID: 11477320
[TBL] [Abstract][Full Text] [Related]
39. Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
Elens L; Veriter S; Di Fazio V; Vanbinst R; Boesmans D; Wallemacq P; Haufroid V
Clin Chem; 2009 Jan; 55(1):170-4. PubMed ID: 19028822
[TBL] [Abstract][Full Text] [Related]
40. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.
Dailly E; Thomas L; Kergueris MF; Jolliet P; Bourin M
J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):129-35. PubMed ID: 11486821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
